Cart
sales@molnova.com
2,5-Dihydroxy-1,4-benzoquinone
CAS No. 615-94-1
2,5-Dihydroxy-1,4-benzoquinone( —— )
Catalog No. M37833 CAS No. 615-94-1
2,5-Dihydroxy-1,4-benzoquinone is a natural product with antimicrobial activity that reduces trophic growth and inhibits spore germination in six fungal species across 12 different genera.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2,5-Dihydroxy-1,4-benzoquinone
-
NoteResearch use only, not for human use.
-
Brief Description2,5-Dihydroxy-1,4-benzoquinone is a natural product with antimicrobial activity that reduces trophic growth and inhibits spore germination in six fungal species across 12 different genera.
-
Description2,5-Dihydroxy-1,4-benzoquinone is a natural product with antimicrobial activity that reduces trophic growth and inhibits spore germination in six fungal species across 12 different genera.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorAntibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number615-94-1
-
Formula Weight140.09
-
Molecular FormulaC6H4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC1=CC(=O)C(O)=CC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
5-Bromo-2’,3’,5’-tri...
5-Bromo-2’,3’,5’-tri-O-acetyluridine is a purine nucleoside analog that is being explored to improve Alzheimer’s and Parkinson’s diseases.
-
Cefprozil
Cefprozil (Cefzil) is a novel cephalosporin antibiotic with antiviral activity for the study of immune system disorders.
-
TBAJ-587
TBAJ-587 is a potent anti-tuberculosis agent. TBAJ-587 inhibits M.tb strain H37Rv growth with MIC90s of 0.006 and <0.02 μg/mL in MABA and LORA assay respectively. BAJ-587 has more potent activity against M. tuberculosis and better efficacy in animal models of TB.
